Ettore Giraldo

This inventor holds 3 USPTO granted patents. Top assignees: Boehringer Ingelheim Pharma Kg, Boehringer Ingelheim Italia. Active years: 1996-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ettore Giraldo. Retrieved from https://idiyas.com/inventor/ettore-giraldo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 83(Granted Patents)

Company Filing History:

2 out of 149

Boehringer Ingelheim Pharma Kg

patents

1 out of 7

Boehringer Ingelheim Italia

patents

Years Active: 1996-2003

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6586435 - Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors (2003-07-01),

2. 6521623 - N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors (2003-02-18),

3. 5576318 - Benzimidazolone derivatives (1996-11-19),

Title: The Innovative Mind of Ettore Giraldo

Introduction: Ettore Giraldo, a visionary inventor hailing from Milan, Italy, has made significant contributions to the world of technology and innovation.

Latest Patents: Ettore Giraldo's latest patents include groundbreaking advancements in renewable energy technologies and sustainable materials.

Career Highlights: Throughout his illustrious career, Ettore Giraldo has been at the forefront of developing cutting-edge solutions in the fields of clean energy, biotechnology, and artificial intelligence.

Collaborations: Ettore Giraldo has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life and make a lasting impact on society.

Conclusion: Ettore Giraldo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]